Financials

News Ideas Technicals Forecast

XERS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Xeris Biopharma Holdings, Inc.

Total assets of XERS for Q1 24 is 336.62 M USD, 1.23% less than the previous Q4 23. And total liabilities decreased by 0.51% in Q1 24 to 345.79 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—